Skip to main content
Premium Trial:

Request an Annual Quote

Deltagen Names New VP, Pharmaceutical Development

NEW YORK, March 26 – Dan Shochat, a former chief scientific officer and senior vice president at Coulter Pharmaceutical, has joined Deltagen as vice president of pharmaceutical development, the company said Monday.

At Deltagen, Shochat will lead the development of drugs for the potential treatment for Acute Myelogenous Leukemia (AML), and other future pharmaceutical development programs, Deltagen CEO William Matthews said in a statement. “Dr. Shochat's extensive expertise in drug discovery and development is a great asset to Deltagen as we move toward the development of our own biotechnology drugs," he said. 

Prior to working at Coulter, Shochat, a biochemist by training, directed biotechnology development at the medical research division of American Cyanamid, where he led an investigation of monoclonal antibodies for the treatment of cancer. 

In November of 2000, Deltagen of Menlo Park, Calif., said that it had licensed an approach to treating AML from the University of Kentucky that targeted CD123, a marker for certain types of leukemia cells. 

Deltagen studies knock-out mice to provide functional genomic and target validation services for pharmaceutical customers, including GlaxoSmithKline, Merck, and Schering-Plough. GlaxoSmithKline and Pfizer subscribe to the company's database, DeltaBase, which contains information about mammalian gene function.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.